Eloxx Pharmaceuticals, Inc. (ELOX)
NASDAQ · Healthcare
Eloxx Pharmaceuticals, Inc. Revenue 2010–2025
Eloxx Pharmaceuticals, Inc. annual/quarterly revenue history and growth rate from 2010 to 2012. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Eloxx Pharmaceuticals, Inc. revenue for the quarter ending December 31, 2012 was 0, a 100.00% decrease year-over-year.
- Eloxx Pharmaceuticals, Inc. annual revenue for 2025 was 0, a 100.00% decrease from 2024.
- Eloxx Pharmaceuticals, Inc. annual revenue for 2024 was 6.4 M.
- Eloxx Pharmaceuticals, Inc. annual revenue for 2023 was 0, a 100.00% decrease from 2014.
- Eloxx Pharmaceuticals, Inc. annual revenue for 2014 was 182229.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Eloxx Pharmaceuticals, Inc. Market Cap — FAQ
Eloxx Pharmaceuticals, Inc. (ELOX) market cap over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see ELOX's market cap history?
The chart and table above show Eloxx Pharmaceuticals, Inc.'s market cap by year and by quarter, including the growth rate.